Laura González-Molero holds a Degree in Pharmacy, industrial specialisation, from the Universidad Complutense de Madrid and an Executive MBA from IE Business School awarded in 1999, and has taken advanced courses in prestigious international academic institutions such as Insead, IMD and Harvard.
She has held senior executive positions in major international corporations in the Healthcare and Chemical sectors in Europe and America.
She was Chairwoman for Latin America at Merck Serono Biopharmaceuticals and Bayer Healthcare, having resided in Brazil and the United States, where she was responsible for more than two thousand five hundred employees and managed business figures in excess of one billion dollars, which has made her an international benchmark in these sectors. Her work as an executive has been rewarded on numerous occasions.
She was an independent Director of Viscofan from 2010 to 2016, and a member of its Appointments and Remuneration Committee, where she carried out an important job promoting and consolidating the functions of this Committee, as well as contributing diversity to the Board's decision-making through her participation in the various debates and deliberations where her criteria and opinion have contributed to the development of the Viscofan Group until the end of her mandate as an independent Director in 2016, when her professional commitments prevented her from considering her renewal as a Director.
She is currently an independent Director of Acerinox SA, Ezentis SA and Bankia SA, Chairwoman of ApD (association for the management progess )member of the Advisory Board of ISS in Spain, a member of Women Corporate Director and International Women Forum, among others.
She is member of the Board of Directors of Viscofan, S.A. and member of its Audit Committee of which she is Chairwoman.
This person is not in the org chart